메뉴 건너뛰기




Volumn 37, Issue 11, 2016, Pages 14341-14354

Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis

Author keywords

Angiogenesis; Natural compounds; Signaling molecules; Tumor

Indexed keywords

ANGIOGENIC FACTOR; ANTINEOPLASTIC AGENT; ARTEMISININ; ARTESUNATE; BEVACIZUMAB; BOSWELLIC ACID; CURCUMIN; CURCUMINOID; EPIGALLOCATECHIN GALLATE; FLUOROURACIL; GINKGO BILOBA EXTRACT; HS 1793; QUERCETIN; RESVERATROL; SCUTELLARIA BAICALENSIS EXTRACT; SILIBININ PHOSPHATIDYLCHOLINE COMPLEX; TAMOXIFEN; UNCLASSIFIED DRUG; ANGIOGENESIS INHIBITOR; ARTEMISININ DERIVATIVE; CATECHIN; PLANT EXTRACT; STILBENE DERIVATIVE; TRITERPENE;

EID: 84986278362     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-016-5330-5     Document Type: Review
Times cited : (24)

References (177)
  • 1
    • 0036692256 scopus 로고    scopus 로고
    • Angiogenesis in health and disease: insights into basic mechanisms and therapeutic opportunities
    • PID: 12214844
    • Polverini PJ. Angiogenesis in health and disease: insights into basic mechanisms and therapeutic opportunities. J Dent Educ. 2002;66:962–75.
    • (2002) J Dent Educ , vol.66 , pp. 962-975
    • Polverini, P.J.1
  • 2
    • 84856014603 scopus 로고    scopus 로고
    • Intussusceptive microvascular growth in tumors
    • COI: 1:CAS:528:DC%2BC38XhtFajt7k%3D, PID: 22197620
    • Ribatti D, Djonov V. Intussusceptive microvascular growth in tumors. Cancer Lett. 2012;316:126–31.
    • (2012) Cancer Lett , vol.316 , pp. 126-131
    • Ribatti, D.1    Djonov, V.2
  • 3
    • 77951672380 scopus 로고    scopus 로고
    • Angiogenesis: future of pharmacological modulation
    • COI: 1:CAS:528:DC%2BC3cXnsl2jtrY%3D, PID: 20606828
    • Bisht M, Dhasmana DC, Bist SS. Angiogenesis: future of pharmacological modulation. Indian J Pharmacol. 2010;42:2–8.
    • (2010) Indian J Pharmacol , vol.42 , pp. 2-8
    • Bisht, M.1    Dhasmana, D.C.2    Bist, S.S.3
  • 4
    • 33947732977 scopus 로고    scopus 로고
    • Angiogenesis: an organizing principle for drug discovery?
    • COI: 1:CAS:528:DC%2BD2sXjs1SisL4%3D, PID: 17396134
    • Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007;6:273–86.
    • (2007) Nat Rev Drug Discov , vol.6 , pp. 273-286
    • Folkman, J.1
  • 5
    • 0037699955 scopus 로고    scopus 로고
    • Angiogenesis in health and disease
    • COI: 1:CAS:528:DC%2BD3sXktFOntbY%3D, PID: 12778163
    • Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9:653–60.
    • (2003) Nat Med , vol.9 , pp. 653-660
    • Carmeliet, P.1
  • 6
    • 59949099437 scopus 로고    scopus 로고
    • Diabetic retinopathy: current management and experimental therapeutic targets
    • COI: 1:CAS:528:DC%2BD1MXjtFGjsLY%3D, PID: 19170588
    • Ali TK, El-Remessy AB. Diabetic retinopathy: current management and experimental therapeutic targets. Pharmacotherapy. 2009;29:182–92.
    • (2009) Pharmacotherapy , vol.29 , pp. 182-192
    • Ali, T.K.1    El-Remessy, A.B.2
  • 7
    • 79951786110 scopus 로고    scopus 로고
    • Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence
    • COI: 1:CAS:528:DC%2BC3MXmsVCmur8%3D
    • Willis LM, El-Remessy AB, Somanath PR, Deremer DL, Fagan SC. Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence. Clin Sci (Lond). 2011;120:307–19.
    • (2011) Clin Sci (Lond) , vol.120 , pp. 307-319
    • Willis, L.M.1    El-Remessy, A.B.2    Somanath, P.R.3    Deremer, D.L.4    Fagan, S.C.5
  • 8
    • 33744954585 scopus 로고    scopus 로고
    • Sunitinib in patients with metastatic renal cell carcinoma
    • COI: 1:CAS:528:DC%2BD28XlsV2rtLk%3D, PID: 16757724
    • Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, et al. Sunitinib in patients with metastatic renal cell carcinoma. JAMA. 2006;295:2516–24.
    • (2006) JAMA , vol.295 , pp. 2516-2524
    • Motzer, R.J.1    Rini, B.I.2    Bukowski, R.M.3    Curti, B.D.4    George, D.J.5    Hudes, G.R.6
  • 10
    • 19444378359 scopus 로고    scopus 로고
    • Use of angiogenesis inhibitors in tumour treatment
    • COI: 1:CAS:528:DC%2BD2MXks1Gjsbc%3D, PID: 15911233
    • Fayette J, Soria JC, Armand JP. Use of angiogenesis inhibitors in tumour treatment. Eur J Cancer. 2005;41:1109–16.
    • (2005) Eur J Cancer , vol.41 , pp. 1109-1116
    • Fayette, J.1    Soria, J.C.2    Armand, J.P.3
  • 11
    • 2542561964 scopus 로고    scopus 로고
    • Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    • COI: 1:CAS:528:DC%2BD2cXks1Gjt74%3D, PID: 15175435
    • Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335–42.
    • (2004) N Engl J Med , vol.350 , pp. 2335-2342
    • Hurwitz, H.1    Fehrenbacher, L.2    Novotny, W.3    Cartwright, T.4    Hainsworth, J.5    Heim, W.6
  • 12
    • 33749238553 scopus 로고    scopus 로고
    • Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
    • COI: 1:CAS:528:DC%2BD28XhtVajsbbM, PID: 17016424
    • Wilhelm S, Carter C, Lynch M, Lowinger T, Dumas J, Smith RA, et al. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat Rev Drug Discov. 2006;5:835–44.
    • (2006) Nat Rev Drug Discov , vol.5 , pp. 835-844
    • Wilhelm, S.1    Carter, C.2    Lynch, M.3    Lowinger, T.4    Dumas, J.5    Smith, R.A.6
  • 13
    • 0034161989 scopus 로고    scopus 로고
    • Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies
    • COI: 1:CAS:528:DC%2BD3cXhvFWrtL0%3D, PID: 10728704
    • Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res. 2000;60:1388–93.
    • (2000) Cancer Res , vol.60 , pp. 1388-1393
    • Eberhard, A.1    Kahlert, S.2    Goede, V.3    Hemmerlein, B.4    Plate, K.H.5    Augustin, H.G.6
  • 14
    • 0032952010 scopus 로고    scopus 로고
    • Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
    • COI: 1:CAS:528:DyaK1MXltFeruw%3D%3D, PID: 9916127
    • Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest. 1999;103:159–65.
    • (1999) J Clin Invest , vol.103 , pp. 159-165
    • Benjamin, L.E.1    Golijanin, D.2    Itin, A.3    Pode, D.4    Keshet, E.5
  • 15
    • 84899420115 scopus 로고    scopus 로고
    • Study to evaluate molecular mechanics behind synergistic chemo-preventive effects of curcumin and resveratrol during lung carcinogenesis
    • PID: 24705375
    • Malhotra A, Nair P, Dhawan DK. Study to evaluate molecular mechanics behind synergistic chemo-preventive effects of curcumin and resveratrol during lung carcinogenesis. PLoS One. 2014;9:e93820.
    • (2014) PLoS One , vol.9
    • Malhotra, A.1    Nair, P.2    Dhawan, D.K.3
  • 16
    • 80054059652 scopus 로고    scopus 로고
    • Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: “reverse pharmacology” and “bedside to bench” approach
    • COI: 1:CAS:528:DC%2BC3MXht1Omt7%2FO, PID: 21561421
    • Aggarwal BB, Prasad S, Reuter S, Kannappan R, Yadev VR, Park B, et al. Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: “reverse pharmacology” and “bedside to bench” approach. Curr Drug Targets. 2011;12:1595–653.
    • (2011) Curr Drug Targets , vol.12 , pp. 1595-1653
    • Aggarwal, B.B.1    Prasad, S.2    Reuter, S.3    Kannappan, R.4    Yadev, V.R.5    Park, B.6
  • 17
    • 0036088478 scopus 로고    scopus 로고
    • Mechanisms of normal and tumor-derived angiogenesis
    • COI: 1:CAS:528:DC%2BD38XjslWltL8%3D, PID: 11940508
    • Papetti M, Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol. 2002;282:C947–70.
    • (2002) Am J Physiol Cell Physiol , vol.282 , pp. C947-C970
    • Papetti, M.1    Herman, I.M.2
  • 18
    • 0030806436 scopus 로고    scopus 로고
    • Angiogenesis: new aspects relating to its initiation and control
    • COI: 1:CAS:528:DyaK2sXlt1WmsL0%3D, PID: 9236859
    • Norrby K. Angiogenesis: new aspects relating to its initiation and control. APMIS. 1997;105:417–37.
    • (1997) APMIS , vol.105 , pp. 417-437
    • Norrby, K.1
  • 19
    • 33646557055 scopus 로고    scopus 로고
    • Angiogenesis—a new target for future therapy
    • COI: 1:CAS:528:DC%2BD28XktVyit7g%3D
    • Pandya NM, Dhalla NS, Santani DD. Angiogenesis—a new target for future therapy. Vasc Pharmacol. 2006;44:265–74.
    • (2006) Vasc Pharmacol , vol.44 , pp. 265-274
    • Pandya, N.M.1    Dhalla, N.S.2    Santani, D.D.3
  • 20
    • 0034092011 scopus 로고    scopus 로고
    • Tumor angiogenesis: past, present and the near future
    • COI: 1:CAS:528:DC%2BD3cXitVeit7w%3D, PID: 10688871
    • Kerbel RS. Tumor angiogenesis: past, present and the near future. Carcinogenesis. 2000;21:505–15.
    • (2000) Carcinogenesis , vol.21 , pp. 505-515
    • Kerbel, R.S.1
  • 21
    • 0030576517 scopus 로고    scopus 로고
    • Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
    • COI: 1:CAS:528:DyaK28XltVSks7s%3D, PID: 8756718
    • Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353–64.
    • (1996) Cell , vol.86 , pp. 353-364
    • Hanahan, D.1    Folkman, J.2
  • 22
    • 70549112270 scopus 로고    scopus 로고
    • The angiogenic switch in carcinogenesis
    • COI: 1:CAS:528:DC%2BD1MXhsV2msbnL, PID: 19482086
    • Baeriswyl V, Christofori G. The angiogenic switch in carcinogenesis. Semin Cancer Biol. 2009;19:329–37.
    • (2009) Semin Cancer Biol , vol.19 , pp. 329-337
    • Baeriswyl, V.1    Christofori, G.2
  • 23
    • 0035721955 scopus 로고    scopus 로고
    • Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis
    • COI: 1:CAS:528:DC%2BD3MXltlamur8%3D, PID: 11451738
    • Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol. 2001;21:1104–17.
    • (2001) Arterioscler Thromb Vasc Biol , vol.21 , pp. 1104-1117
    • Pepper, M.S.1
  • 24
    • 0026639806 scopus 로고
    • Angiogenesis
    • COI: 1:CAS:528:DyaK38XksVSmu7s%3D, PID: 1375931
    • Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931–4.
    • (1992) J Biol Chem , vol.267 , pp. 10931-10934
    • Folkman, J.1    Shing, Y.2
  • 25
    • 0027563591 scopus 로고
    • Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
    • COI: 1:STN:280:DyaK3s3jtVemtA%3D%3D, PID: 7682469
    • Denekamp J. Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol. 1993;66:181–96.
    • (1993) Br J Radiol , vol.66 , pp. 181-196
    • Denekamp, J.1
  • 26
    • 53349117817 scopus 로고    scopus 로고
    • (−)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells
    • COI: 1:CAS:528:DC%2BD1cXht1SitLvI, PID: 18586691
    • Adachi S, Nagao T, To S, Joe AK, Shimizu M, Matsushima-Nishiwaki R, et al. (−)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells. Carcinogenesis. 2008;29:1986–93.
    • (2008) Carcinogenesis , vol.29 , pp. 1986-1993
    • Adachi, S.1    Nagao, T.2    To, S.3    Joe, A.K.4    Shimizu, M.5    Matsushima-Nishiwaki, R.6
  • 27
    • 2642565248 scopus 로고    scopus 로고
    • Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines
    • PID: 15173038
    • Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. Circulation. 2004;109:2487–91.
    • (2004) Circulation , vol.109 , pp. 2487-2491
    • Losordo, D.W.1    Dimmeler, S.2
  • 28
    • 14544305077 scopus 로고    scopus 로고
    • Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions
    • COI: 1:CAS:528:DC%2BD2MXitl2gu74%3D, PID: 15718328
    • Gasparini G, Longo R, Fanelli M, Teicher BA. Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions. J Clin Oncol. 2005;23:1295–311.
    • (2005) J Clin Oncol , vol.23 , pp. 1295-1311
    • Gasparini, G.1    Longo, R.2    Fanelli, M.3    Teicher, B.A.4
  • 29
    • 0024818355 scopus 로고
    • Vascular endothelial growth factor is a secreted angiogenic mitogen
    • COI: 1:CAS:528:DyaK3cXls1GltLo%3D, PID: 2479986
    • Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306–9.
    • (1989) Science , vol.246 , pp. 1306-1309
    • Leung, D.W.1    Cachianes, G.2    Kuang, W.J.3    Goeddel, D.V.4    Ferrara, N.5
  • 30
    • 0029166443 scopus 로고
    • Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis
    • COI: 1:STN:280:DyaK28%2FkvFOquw%3D%3D, PID: 8534863
    • Kolch W, Martiny-Baron G, Kieser A, Marme D. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res Treat. 1995;36:139–55.
    • (1995) Breast Cancer Res Treat , vol.36 , pp. 139-155
    • Kolch, W.1    Martiny-Baron, G.2    Kieser, A.3    Marme, D.4
  • 32
    • 0025212688 scopus 로고
    • Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis
    • COI: 1:CAS:528:DyaK3cXitFCqtLY%3D, PID: 1691500
    • Motro B, Itin A, Sachs L, Keshet E. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci U S A. 1990;87:3092–6.
    • (1990) Proc Natl Acad Sci U S A , vol.87 , pp. 3092-3096
    • Motro, B.1    Itin, A.2    Sachs, L.3    Keshet, E.4
  • 33
    • 0029397625 scopus 로고
    • Cytokines and tumors of the central nervous system
    • COI: 1:STN:280:DyaK287lslGgsQ%3D%3D, PID: 8586463
    • Van Meir EG. Cytokines and tumors of the central nervous system. Glia. 1995;15:264–88.
    • (1995) Glia , vol.15 , pp. 264-288
    • Van Meir, E.G.1
  • 34
    • 0036791813 scopus 로고    scopus 로고
    • Inhibitory effects of Ginkgo biloba extract on vascular endothelial growth factor in rat aortic endothelial cells
    • COI: 1:CAS:528:DC%2BD38XnvFGlu7s%3D, PID: 12370096
    • Zhang L, Rui YC, Yang PY, Qiu Y, Li TJ, Liu HC. Inhibitory effects of Ginkgo biloba extract on vascular endothelial growth factor in rat aortic endothelial cells. Acta Pharmacol Sin. 2002;23:919–23.
    • (2002) Acta Pharmacol Sin , vol.23 , pp. 919-923
    • Zhang, L.1    Rui, Y.C.2    Yang, P.Y.3    Qiu, Y.4    Li, T.J.5    Liu, H.C.6
  • 35
    • 24744471877 scopus 로고    scopus 로고
    • Mechanism of action of (−)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells
    • COI: 1:CAS:528:DC%2BD2MXpslahsL0%3D, PID: 16140980
    • Hou Z, Sang S, You H, Lee MJ, Hong J, Chin KV, et al. Mechanism of action of (−)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res. 2005;65:8049–56.
    • (2005) Cancer Res , vol.65 , pp. 8049-8056
    • Hou, Z.1    Sang, S.2    You, H.3    Lee, M.J.4    Hong, J.5    Chin, K.V.6
  • 36
    • 0026568694 scopus 로고
    • Dual role of tumor necrosis factor-alpha in angiogenesis
    • COI: 1:CAS:528:DyaK38Xitlemsb0%3D, PID: 1372154
    • Fajardo LF, Kwan HH, Kowalski J, Prionas SD, Allison AC. Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol. 1992;140:539–44.
    • (1992) Am J Pathol , vol.140 , pp. 539-544
    • Fajardo, L.F.1    Kwan, H.H.2    Kowalski, J.3    Prionas, S.D.4    Allison, A.C.5
  • 37
    • 0030012507 scopus 로고    scopus 로고
    • Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology
    • COI: 1:CAS:528:DyaK28Xktlyls7w%3D, PID: 8773299
    • Jendraschak E, Sage EH. Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology. Semin Cancer Biol. 1996;7:139–46.
    • (1996) Semin Cancer Biol , vol.7 , pp. 139-146
    • Jendraschak, E.1    Sage, E.H.2
  • 38
    • 3042748129 scopus 로고    scopus 로고
    • Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy
    • COI: 1:CAS:528:DC%2BD2cXls1Oltbo%3D, PID: 15179620
    • Gately S, Li WW. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin Oncol. 2004;31:2–11.
    • (2004) Semin Oncol , vol.31 , pp. 2-11
    • Gately, S.1    Li, W.W.2
  • 39
    • 33745873484 scopus 로고    scopus 로고
    • Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells
    • COI: 1:CAS:528:DC%2BD28XmsVagtL8%3D, PID: 16638750
    • Nie D, Krishnamoorthy S, Jin R, Tang K, Chen Y, Qiao Y, et al. Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells. J Biol Chem. 2006;281:18601–9.
    • (2006) J Biol Chem , vol.281 , pp. 18601-18609
    • Nie, D.1    Krishnamoorthy, S.2    Jin, R.3    Tang, K.4    Chen, Y.5    Qiao, Y.6
  • 40
    • 6944243800 scopus 로고    scopus 로고
    • Reduction of CWR22 prostate tumor xenograft growth by combined tamoxifen-quercetin treatment is associated with inhibition of angiogenesis and cellular proliferation
    • COI: 1:CAS:528:DC%2BD2cXjvVGnsbY%3D, PID: 15067354
    • Ma ZS, Huynh TH, Ng CP, Do PT, Nguyen TH, Huynh H. Reduction of CWR22 prostate tumor xenograft growth by combined tamoxifen-quercetin treatment is associated with inhibition of angiogenesis and cellular proliferation. Int J Oncol. 2004;24:1297–304.
    • (2004) Int J Oncol , vol.24 , pp. 1297-1304
    • Ma, Z.S.1    Huynh, T.H.2    Ng, C.P.3    Do, P.T.4    Nguyen, T.H.5    Huynh, H.6
  • 41
  • 42
    • 0032907687 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF) and its receptors
    • COI: 1:CAS:528:DyaK1MXlt1ygsQ%3D%3D, PID: 9872925
    • Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9–22.
    • (1999) FASEB J , vol.13 , pp. 9-22
    • Neufeld, G.1    Cohen, T.2    Gengrinovitch, S.3    Poltorak, Z.4
  • 43
    • 0038391043 scopus 로고    scopus 로고
    • Mechanism and its regulation of tumor-induced angiogenesis
    • COI: 1:CAS:528:DC%2BD3sXlvVSrtb4%3D, PID: 12800214
    • Gupta MK, Qin RY. Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol. 2003;9:1144–55.
    • (2003) World J Gastroenterol , vol.9 , pp. 1144-1155
    • Gupta, M.K.1    Qin, R.Y.2
  • 44
    • 84898916061 scopus 로고    scopus 로고
    • Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells
    • COI: 1:CAS:528:DC%2BC2cXls1Ogu7Y%3D, PID: 24048742
    • Huang YH, Yang HY, Hsu YF, Chiu PT, Ou G, Hsu MJ. Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells. Angiogenesis. 2014;17:407–18.
    • (2014) Angiogenesis , vol.17 , pp. 407-418
    • Huang, Y.H.1    Yang, H.Y.2    Hsu, Y.F.3    Chiu, P.T.4    Ou, G.5    Hsu, M.J.6
  • 45
    • 84892917277 scopus 로고    scopus 로고
    • Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction
    • COI: 1:CAS:528:DC%2BC3sXhvFCru7%2FN, PID: 24346288
    • Nagasaki T, Hara M, Nakanishi H, Takahashi H, Sato M, Takeyama H. Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction. Br J Cancer. 2014;110:469–78.
    • (2014) Br J Cancer , vol.110 , pp. 469-478
    • Nagasaki, T.1    Hara, M.2    Nakanishi, H.3    Takahashi, H.4    Sato, M.5    Takeyama, H.6
  • 46
    • 31544465706 scopus 로고    scopus 로고
    • Roles of myofibroblasts in prostaglandin E2-stimulated intestinal epithelial proliferation and angiogenesis
    • COI: 1:CAS:528:DC%2BD28XlsFOrtQ%3D%3D, PID: 16424017
    • Shao J, Sheng GG, Mifflin RC, Powell DW, Sheng H. Roles of myofibroblasts in prostaglandin E2-stimulated intestinal epithelial proliferation and angiogenesis. Cancer Res. 2006;66:846–55.
    • (2006) Cancer Res , vol.66 , pp. 846-855
    • Shao, J.1    Sheng, G.G.2    Mifflin, R.C.3    Powell, D.W.4    Sheng, H.5
  • 47
    • 80052211625 scopus 로고    scopus 로고
    • Angiopoietin-1 and -2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis
    • COI: 1:CAS:528:DC%2BC3MXhtFSmtbrI, PID: 21778249
    • Fagiani E, Lorentz P, Kopfstein L, Christofori G. Angiopoietin-1 and -2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis. Cancer Res. 2011;71:5717–27.
    • (2011) Cancer Res , vol.71 , pp. 5717-5727
    • Fagiani, E.1    Lorentz, P.2    Kopfstein, L.3    Christofori, G.4
  • 48
    • 84920149720 scopus 로고    scopus 로고
    • Cyclooxygenase-2 and the inflammogenesis of breast cancer
    • PID: 25302170
    • Harris RE, Casto BC, Harris ZM. Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J Clin Oncol. 2014;5:677–92.
    • (2014) World J Clin Oncol , vol.5 , pp. 677-692
    • Harris, R.E.1    Casto, B.C.2    Harris, Z.M.3
  • 49
    • 84896714208 scopus 로고    scopus 로고
    • The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies
    • COI: 1:CAS:528:DC%2BC2cXjt1agsbc%3D, PID: 24483845
    • Vosooghi M, Amini M. The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies. Expert Opin Drug Discov. 2014;9:255–67.
    • (2014) Expert Opin Drug Discov , vol.9 , pp. 255-267
    • Vosooghi, M.1    Amini, M.2
  • 50
    • 84909591975 scopus 로고    scopus 로고
    • Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase
    • PID: 25152576
    • Knab LM, Grippo PJ, Bentrem DJ. Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase. World J Gastroenterol. 2014;20:10729–39.
    • (2014) World J Gastroenterol , vol.20 , pp. 10729-10739
    • Knab, L.M.1    Grippo, P.J.2    Bentrem, D.J.3
  • 51
    • 84946412063 scopus 로고    scopus 로고
    • Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity
    • Liu B, Qu L, Yan S. Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity. Cancer Cell Int. 2015.
    • (2015) Cancer Cell Int
    • Liu, B.1    Qu, L.2    Yan, S.3
  • 53
    • 34548254050 scopus 로고    scopus 로고
    • COX-2 expression in invasive breast cancer: correlation with prognostic parameters and outcome
    • COI: 1:CAS:528:DC%2BD2sXhtFGqu7bP, PID: 17721268
    • Nassar A, Radhakrishnan A, Cabrero IA, Cotsonis G, Cohen C. COX-2 expression in invasive breast cancer: correlation with prognostic parameters and outcome. Appl Immunohistochem Mol Morphol. 2007;15:255–9.
    • (2007) Appl Immunohistochem Mol Morphol , vol.15 , pp. 255-259
    • Nassar, A.1    Radhakrishnan, A.2    Cabrero, I.A.3    Cotsonis, G.4    Cohen, C.5
  • 54
    • 0344010548 scopus 로고    scopus 로고
    • Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase
    • COI: 1:CAS:528:DC%2BD3sXos1amt78%3D, PID: 14669797
    • Nie D, Nemeth J, Qiao Y, Zacharek A, Li L, Hanna K, et al. Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Clin Exp Metastasis. 2003;20:657–63.
    • (2003) Clin Exp Metastasis , vol.20 , pp. 657-663
    • Nie, D.1    Nemeth, J.2    Qiao, Y.3    Zacharek, A.4    Li, L.5    Hanna, K.6
  • 55
    • 84865117886 scopus 로고    scopus 로고
    • Molecular mechanism inhibiting human hepatocarcinoma cell invasion by 6-shogaol and 6-gingerol
    • COI: 1:CAS:528:DC%2BC38XovValtbg%3D, PID: 22714996
    • Weng CJ, Chou CP, Ho CT, Yen GC. Molecular mechanism inhibiting human hepatocarcinoma cell invasion by 6-shogaol and 6-gingerol. Mol Nutr Food Res. 2012;56:1304–14.
    • (2012) Mol Nutr Food Res , vol.56 , pp. 1304-1314
    • Weng, C.J.1    Chou, C.P.2    Ho, C.T.3    Yen, G.C.4
  • 57
    • 80052886108 scopus 로고    scopus 로고
    • Emerging pathways and future targets for the molecular therapy of pancreatic cancer
    • COI: 1:CAS:528:DC%2BC3MXhtFOmur3I, PID: 21819318
    • Vaccaro V, Melisi D, Bria E, Cuppone F, Ciuffreda L, Pino MS, et al. Emerging pathways and future targets for the molecular therapy of pancreatic cancer. Expert Opin Ther Targets. 2011;15:1183–96.
    • (2011) Expert Opin Ther Targets , vol.15 , pp. 1183-1196
    • Vaccaro, V.1    Melisi, D.2    Bria, E.3    Cuppone, F.4    Ciuffreda, L.5    Pino, M.S.6
  • 58
    • 80054119583 scopus 로고    scopus 로고
    • Nuclear factor-kappaB: a key regulator in health and disease of lungs
    • COI: 1:CAS:528:DC%2BC3MXhtFyjtrzN
    • Batra S, Balamayooran G, Sahoo MK. Nuclear factor-kappaB: a key regulator in health and disease of lungs. Arch Immunol Ther Exp. 2011;59:335–51.
    • (2011) Arch Immunol Ther Exp , vol.59 , pp. 335-351
    • Batra, S.1    Balamayooran, G.2    Sahoo, M.K.3
  • 59
    • 0032588186 scopus 로고    scopus 로고
    • NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1
    • COI: 1:CAS:528:DyaK1MXkvVKjtrc%3D, PID: 10409765
    • Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin Jr AS. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol. 1999;19:5785–99.
    • (1999) Mol Cell Biol , vol.19 , pp. 5785-5799
    • Guttridge, D.C.1    Albanese, C.2    Reuther, J.Y.3    Pestell, R.G.4    Baldwin, A.S.5
  • 60
    • 4344612243 scopus 로고    scopus 로고
    • NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
    • COI: 1:CAS:528:DC%2BD2cXmvVelsrY%3D, PID: 15314694
    • Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, et al. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest. 2004;114:569–81.
    • (2004) J Clin Invest , vol.114 , pp. 569-581
    • Huber, M.A.1    Azoitei, N.2    Baumann, B.3    Grunert, S.4    Sommer, A.5    Pehamberger, H.6
  • 61
    • 33845955238 scopus 로고    scopus 로고
    • A novel mechanism of tissue inhibitor of metalloproteinases-1 activation by interleukin-1 in primary human astrocytes
    • COI: 1:CAS:528:DC%2BD28XhtF2gtbnO, PID: 17012236
    • Wilczynska KM, Gopalan SM, Bugno M, Kasza A, Konik BS, Bryan L, et al. A novel mechanism of tissue inhibitor of metalloproteinases-1 activation by interleukin-1 in primary human astrocytes. J Biol Chem. 2006;281:34955–64.
    • (2006) J Biol Chem , vol.281 , pp. 34955-34964
    • Wilczynska, K.M.1    Gopalan, S.M.2    Bugno, M.3    Kasza, A.4    Konik, B.S.5    Bryan, L.6
  • 62
    • 37549068860 scopus 로고    scopus 로고
    • Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis
    • COI: 1:CAS:528:DC%2BD1cXht1Siug%3D%3D, PID: 17979497
    • Liu RM. Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis. Antioxid Redox Signal. 2008;10:303–19.
    • (2008) Antioxid Redox Signal , vol.10 , pp. 303-319
    • Liu, R.M.1
  • 63
    • 51049090204 scopus 로고    scopus 로고
    • Nanoparticle therapeutics: an emerging treatment modality for cancer
    • COI: 1:CAS:528:DC%2BD1cXhtVGgtL%2FJ, PID: 18758474
    • Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7:771–82.
    • (2008) Nat Rev Drug Discov , vol.7 , pp. 771-782
    • Davis, M.E.1    Chen, Z.G.2    Shin, D.M.3
  • 64
    • 0036842215 scopus 로고    scopus 로고
    • Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy
    • COI: 1:CAS:528:DC%2BD38Xpt1CjtL0%3D, PID: 12409337
    • Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol. 2002;20:4368–80.
    • (2002) J Clin Oncol , vol.20 , pp. 4368-4380
    • Dvorak, H.F.1
  • 65
    • 33646107369 scopus 로고    scopus 로고
    • VEGF Receptor signalling - in control of vascular function
    • COI: 1:CAS:528:DC%2BD28XjslSktrc%3D, PID: 16633338
    • Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF Receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006;7:359–71.
    • (2006) Nat Rev Mol Cell Biol , vol.7 , pp. 359-371
    • Olsson, A.K.1    Dimberg, A.2    Kreuger, J.3    Claesson-Welsh, L.4
  • 66
    • 33845490014 scopus 로고    scopus 로고
    • Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
    • COI: 1:CAS:528:DC%2BD28XhtlWqsbzI, PID: 17167137
    • Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med. 2006;355:2542–50.
    • (2006) N Engl J Med , vol.355 , pp. 2542-2550
    • Sandler, A.1    Gray, R.2    Perry, M.C.3    Brahmer, J.4    Schiller, J.H.5    Dowlati, A.6
  • 67
    • 37549040613 scopus 로고    scopus 로고
    • Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
    • COI: 1:CAS:528:DC%2BD1cXisVOnsg%3D%3D, PID: 18160686
    • Miller K, Wang M, Gralow J, Dickler M, Cobleigh M, Perez EA, et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med. 2007;357:2666–76.
    • (2007) N Engl J Med , vol.357 , pp. 2666-2676
    • Miller, K.1    Wang, M.2    Gralow, J.3    Dickler, M.4    Cobleigh, M.5    Perez, E.A.6
  • 68
    • 84924901853 scopus 로고    scopus 로고
    • Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240
    • COI: 1:CAS:528:DC%2BC2MXhvVOqsL4%3D, PID: 25638326
    • Penson RT, Huang HQ, Wenzel LB, Monk BJ, Stockman S, Long 3rd HJ, et al. Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240. Lancet Oncol. 2015;16:301–11.)
    • (2015) Lancet Oncol , vol.16 , pp. 301-311
    • Penson, R.T.1    Huang, H.Q.2    Wenzel, L.B.3    Monk, B.J.4    Stockman, S.5    Long, H.J.6
  • 69
    • 77956903170 scopus 로고    scopus 로고
    • Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy
    • COI: 1:CAS:528:DC%2BC3cXhtVCkurzI, PID: 20426765
    • Niu G, Chen X. Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Curr Drug Targets. 2010;11:1000–17.
    • (2010) Curr Drug Targets , vol.11 , pp. 1000-1017
    • Niu, G.1    Chen, X.2
  • 70
    • 33846148701 scopus 로고    scopus 로고
    • Sorafenib in advanced clear-cell renal-cell carcinoma
    • COI: 1:CAS:528:DC%2BD2sXksVKitg%3D%3D, PID: 17215530
    • Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 2007;356:125–34.
    • (2007) N Engl J Med , vol.356 , pp. 125-134
    • Escudier, B.1    Eisen, T.2    Stadler, W.M.3    Szczylik, C.4    Oudard, S.5    Siebels, M.6
  • 72
    • 55749088393 scopus 로고    scopus 로고
    • Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
    • COI: 1:CAS:528:DC%2BD1cXht1ensLfE, PID: 18852116
    • Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther. 2008;7:3129–40.
    • (2008) Mol Cancer Ther , vol.7 , pp. 3129-3140
    • Wilhelm, S.M.1    Adnane, L.2    Newell, P.3    Villanueva, A.4    Llovet, J.M.5    Lynch, M.6
  • 73
    • 33644921230 scopus 로고    scopus 로고
    • Tipifarnib: farnesyl transferase inhibition at a crossroads
    • COI: 1:CAS:528:DC%2BD28XivV2ltrg%3D, PID: 16503848
    • Mesa RA. Tipifarnib: farnesyl transferase inhibition at a crossroads. Expert Rev Anticancer Ther. 2006;6:313–9.
    • (2006) Expert Rev Anticancer Ther , vol.6 , pp. 313-319
    • Mesa, R.A.1
  • 74
    • 14344254868 scopus 로고    scopus 로고
    • Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice
    • COI: 1:CAS:528:DyaK1cXnt1yisLg%3D, PID: 9810004
    • Liu M, Bryant MS, Chen J, Lee S, Yaremko B, Lipari P, et al. Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. Cancer Res. 1998;58:4947–56.
    • (1998) Cancer Res , vol.58 , pp. 4947-4956
    • Liu, M.1    Bryant, M.S.2    Chen, J.3    Lee, S.4    Yaremko, B.5    Lipari, P.6
  • 75
    • 33746637660 scopus 로고    scopus 로고
    • Current development of mTOR inhibitors as anticancer agents
    • COI: 1:CAS:528:DC%2BD28XnsFCkurk%3D, PID: 16883305
    • Faivre S, Kroemer G, Raymond E. Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov. 2006;5:671–88.
    • (2006) Nat Rev Drug Discov , vol.5 , pp. 671-688
    • Faivre, S.1    Kroemer, G.2    Raymond, E.3
  • 76
    • 33750344252 scopus 로고    scopus 로고
    • Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events
    • COI: 1:CAS:528:DC%2BD28Xhtlajt7vM, PID: 17145522
    • Hurwitz H, Saini S. Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events. Semin Oncol. 2006;33:S26–34.
    • (2006) Semin Oncol , vol.33 , pp. S26-S34
    • Hurwitz, H.1    Saini, S.2
  • 77
    • 77955476115 scopus 로고    scopus 로고
    • Bleeding complications of antiangiogenic therapy: pathogenetic mechanisms and clinical impact
    • PID: 20434006
    • Elice F, Rodeghiero F. Bleeding complications of antiangiogenic therapy: pathogenetic mechanisms and clinical impact. Thromb Res. 2010;125(Suppl 2):S55–7.
    • (2010) Thromb Res , vol.125 , pp. S55-S57
    • Elice, F.1    Rodeghiero, F.2
  • 78
    • 34249294557 scopus 로고    scopus 로고
    • Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition
    • COI: 1:CAS:528:DC%2BD2sXls1Kjsb4%3D, PID: 17522716
    • Verheul HM, Pinedo HM. Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition. Nat Rev Cancer. 2007;7:475–85.
    • (2007) Nat Rev Cancer , vol.7 , pp. 475-485
    • Verheul, H.M.1    Pinedo, H.M.2
  • 79
    • 34247849335 scopus 로고    scopus 로고
    • Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer
    • COI: 1:CAS:528:DC%2BD2sXmtlSitrk%3D, PID: 17470687
    • Los M, Roodhart JM, Voest EE. Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer. Oncologist. 2007;12:443–50.
    • (2007) Oncologist , vol.12 , pp. 443-450
    • Los, M.1    Roodhart, J.M.2    Voest, E.E.3
  • 80
    • 0037208589 scopus 로고    scopus 로고
    • Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer
    • COI: 1:CAS:528:DC%2BD2cXpsVWru7Y%3D, PID: 12506171
    • Kabbinavar F, Hurwitz HI, Fehrenbacher L, Meropol NJ, Novotny WF, Lieberman G, et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol. 2003;21:60–5.
    • (2003) J Clin Oncol , vol.21 , pp. 60-65
    • Kabbinavar, F.1    Hurwitz, H.I.2    Fehrenbacher, L.3    Meropol, N.J.4    Novotny, W.F.5    Lieberman, G.6
  • 81
    • 34248173883 scopus 로고    scopus 로고
    • Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200
    • COI: 1:CAS:528:DC%2BD2sXlsVyntbc%3D, PID: 17442997
    • Giantonio BJ, Catalano PJ, Meropol NJ, O’Dwyer PJ, Mitchell EP, Alberts SR, et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol. 2007;25:1539–44.
    • (2007) J Clin Oncol , vol.25 , pp. 1539-1544
    • Giantonio, B.J.1    Catalano, P.J.2    Meropol, N.J.3    O’Dwyer, P.J.4    Mitchell, E.P.5    Alberts, S.R.6
  • 82
    • 2942657615 scopus 로고    scopus 로고
    • Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
    • COI: 1:CAS:528:DC%2BD2cXpsVWltrg%3D, PID: 15169807
    • Johnson DH, Fehrenbacher L, Novotny WF, Herbst RS, Nemunaitis JJ, Jablons DM, et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol. 2004;22:2184–91.
    • (2004) J Clin Oncol , vol.22 , pp. 2184-2191
    • Johnson, D.H.1    Fehrenbacher, L.2    Novotny, W.F.3    Herbst, R.S.4    Nemunaitis, J.J.5    Jablons, D.M.6
  • 83
    • 0034991938 scopus 로고    scopus 로고
    • Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice
    • COI: 1:CAS:528:DC%2BD3MXkt12ksbg%3D, PID: 11385077
    • Kimura Y, Okuda H. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr. 2001;131:1844–9.
    • (2001) J Nutr , vol.131 , pp. 1844-1849
    • Kimura, Y.1    Okuda, H.2
  • 84
    • 0036733776 scopus 로고    scopus 로고
    • Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9
    • COI: 1:CAS:528:DC%2BD38Xmslylu7s%3D, PID: 12208745
    • Banerjee S, Bueso-Ramos C, Aggarwal BB. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 2002;62:4945–54.
    • (2002) Cancer Res , vol.62 , pp. 4945-4954
    • Banerjee, S.1    Bueso-Ramos, C.2    Aggarwal, B.B.3
  • 85
    • 43049100156 scopus 로고    scopus 로고
    • Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-part 1
    • COI: 1:STN:280:DC%2BD2szmt1Whtg%3D%3D, PID: 17576437
    • Sagar SM, Yance D, Wong RK. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-part 1. Curr Oncol. 2006;13:14–26.
    • (2006) Curr Oncol , vol.13 , pp. 14-26
    • Sagar, S.M.1    Yance, D.2    Wong, R.K.3
  • 86
    • 3242664189 scopus 로고    scopus 로고
    • Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate
    • COI: 1:CAS:528:DC%2BD2cXlvVegsL8%3D, PID: 15269163
    • Fassina G, Vene R, Morini M, Minghelli S, Benelli R, Noonan DM, et al. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin Cancer Res. 2004;10:4865–73.
    • (2004) Clin Cancer Res , vol.10 , pp. 4865-4873
    • Fassina, G.1    Vene, R.2    Morini, M.3    Minghelli, S.4    Benelli, R.5    Noonan, D.M.6
  • 87
    • 0037189026 scopus 로고    scopus 로고
    • Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding
    • COI: 1:CAS:528:DC%2BD38XivVSgtLw%3D, PID: 12175544
    • Kondo T, Ohta T, Igura K, Hara Y, Kaji K. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Lett. 2002;180:139–44.
    • (2002) Cancer Lett , vol.180 , pp. 139-144
    • Kondo, T.1    Ohta, T.2    Igura, K.3    Hara, Y.4    Kaji, K.5
  • 88
    • 0038353308 scopus 로고    scopus 로고
    • Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors
    • COI: 1:CAS:528:DC%2BD3sXltF2ntrs%3D, PID: 12850245
    • Kojima-Yuasa A, Hua JJ, Kennedy DO, Matsui-Yuasa I. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors. Life Sci. 2003;73:1299–313.
    • (2003) Life Sci , vol.73 , pp. 1299-1313
    • Kojima-Yuasa, A.1    Hua, J.J.2    Kennedy, D.O.3    Matsui-Yuasa, I.4
  • 89
    • 0037081274 scopus 로고    scopus 로고
    • Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation
    • COI: 1:CAS:528:DC%2BD38XhtVyhsbc%3D, PID: 11809684
    • Lamy S, Gingras D, Beliveau R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res. 2002;62:381–5.
    • (2002) Cancer Res , vol.62 , pp. 381-385
    • Lamy, S.1    Gingras, D.2    Beliveau, R.3
  • 90
    • 84877314894 scopus 로고    scopus 로고
    • EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1alpha and NFkappaB, and VEGF expression
    • COI: 1:CAS:528:DC%2BC3sXot1ygtbY%3D, PID: 23638734
    • Gu JW, Makey KL, Tucker KB, Chinchar E, Mao X, Pei I, et al. EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1alpha and NFkappaB, and VEGF expression. Vasc Cell. 2013;5:9.
    • (2013) Vasc Cell , vol.5 , pp. 9
    • Gu, J.W.1    Makey, K.L.2    Tucker, K.B.3    Chinchar, E.4    Mao, X.5    Pei, I.6
  • 91
    • 34447628307 scopus 로고    scopus 로고
    • Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells
    • COI: 1:CAS:528:DC%2BD2sXot1ylsr4%3D
    • Zhou HJ, Wang WQ, Wu GD, Lee J, Li A. Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells. Vasc Pharmacol. 2007;47:131–8.
    • (2007) Vasc Pharmacol , vol.47 , pp. 131-138
    • Zhou, H.J.1    Wang, W.Q.2    Wu, G.D.3    Lee, J.4    Li, A.5
  • 92
    • 33644854366 scopus 로고    scopus 로고
    • Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex
    • COI: 1:CAS:528:DC%2BD28XislKlsrY%3D, PID: 16217757
    • Rodriguez SK, Guo W, Liu L, Band MA, Paulson EK, Meydani M. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer. 2006;118:1635–44.
    • (2006) Int J Cancer , vol.118 , pp. 1635-1644
    • Rodriguez, S.K.1    Guo, W.2    Liu, L.3    Band, M.A.4    Paulson, E.K.5    Meydani, M.6
  • 93
    • 0030930265 scopus 로고    scopus 로고
    • Suppression of extracellular signals and cell proliferation through EGF receptor binding by (−)-epigallocatechin gallate in human A431 epidermoid carcinoma cells
    • COI: 1:CAS:528:DyaK2sXmvFCnt7c%3D, PID: 9328839
    • Liang YC, Lin-shiau SY, Chen CF, Lin JK. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (−)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem. 1997;67:55–65.
    • (1997) J Cell Biochem , vol.67 , pp. 55-65
    • Liang, Y.C.1    Lin-shiau, S.Y.2    Chen, C.F.3    Lin, J.K.4
  • 94
    • 34447129573 scopus 로고    scopus 로고
    • The inhibitory effect of (−)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells
    • COI: 1:CAS:528:DC%2BD2sXnsVyqur8%3D, PID: 17616711
    • Adachi S, Nagao T, Ingolfsson HI, Maxfield FR, Andersen OS, Kopelovich L, et al. The inhibitory effect of (−)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res. 2007;67:6493–501.
    • (2007) Cancer Res , vol.67 , pp. 6493-6501
    • Adachi, S.1    Nagao, T.2    Ingolfsson, H.I.3    Maxfield, F.R.4    Andersen, O.S.5    Kopelovich, L.6
  • 96
    • 0034615942 scopus 로고    scopus 로고
    • Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B
    • COI: 1:CAS:528:DC%2BD3cXisFWjt70%3D, PID: 10744729
    • Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, Kasahara N, et al. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem. 2000;275:10405–12.
    • (2000) J Biol Chem , vol.275 , pp. 10405-10412
    • Mohan, R.1    Sivak, J.2    Ashton, P.3    Russo, L.A.4    Pham, B.Q.5    Kasahara, N.6
  • 97
    • 54349091392 scopus 로고    scopus 로고
    • Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition
    • COI: 1:CAS:528:DC%2BD1cXhtl2gtr7K, PID: 18596194
    • Binion DG, Otterson MF, Rafiee P. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut. 2008;57:1509–17.
    • (2008) Gut , vol.57 , pp. 1509-1517
    • Binion, D.G.1    Otterson, M.F.2    Rafiee, P.3
  • 98
    • 84866295392 scopus 로고    scopus 로고
    • Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas
    • COI: 1:CAS:528:DC%2BC38XhsVGitrnE, PID: 22739211
    • Shan B, Schaaf C, Schmidt A, Lucia K, Buchfelder M, Losa M, et al. Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas. J Endocrinol. 2012;214:389–98.
    • (2012) J Endocrinol , vol.214 , pp. 389-398
    • Shan, B.1    Schaaf, C.2    Schmidt, A.3    Lucia, K.4    Buchfelder, M.5    Losa, M.6
  • 99
    • 34250170761 scopus 로고    scopus 로고
    • Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1
    • COI: 1:CAS:528:DC%2BD28XlvVOisL0%3D, PID: 16685395
    • Bae MK, Kim SH, Jeong JW, Lee YM, Kim HS, Kim SR, et al. Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1. Oncol Rep. 2006;15:1557–62.
    • (2006) Oncol Rep , vol.15 , pp. 1557-1562
    • Bae, M.K.1    Kim, S.H.2    Jeong, J.W.3    Lee, Y.M.4    Kim, H.S.5    Kim, S.R.6
  • 101
    • 78650859920 scopus 로고    scopus 로고
    • Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing mice
    • COI: 1:CAS:528:DC%2BC3MXhs1Khtw%3D%3D, PID: 21114990
    • El-Azab M, Hishe H, Moustafa Y, El-Awadyel S. Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing mice. Eur J Pharmacol. 2011;652:7–14.
    • (2011) Eur J Pharmacol , vol.652 , pp. 7-14
    • El-Azab, M.1    Hishe, H.2    Moustafa, Y.3    El-Awadyel, S.4
  • 102
    • 3242773727 scopus 로고    scopus 로고
    • Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis
    • COI: 1:CAS:528:DC%2BD2cXmtVajs7g%3D, PID: 15358181
    • Hahm ER, Gho YS, Park S, Park C, Kim KW, Yang CH. Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis. Biochem Biophys Res Commun. 2004;321:337–44.
    • (2004) Biochem Biophys Res Commun , vol.321 , pp. 337-344
    • Hahm, E.R.1    Gho, Y.S.2    Park, S.3    Park, C.4    Kim, K.W.5    Yang, C.H.6
  • 103
    • 9144231812 scopus 로고    scopus 로고
    • Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis
    • COI: 1:CAS:528:DC%2BD2cXivVChsr0%3D, PID: 14722241
    • Chen HW, Yu SL, Chen JJ, Li HN, Lin YC, Yao PL, et al. Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol Pharmacol. 2004;65:99–110.
    • (2004) Mol Pharmacol , vol.65 , pp. 99-110
    • Chen, H.W.1    Yu, S.L.2    Chen, J.J.3    Li, H.N.4    Lin, Y.C.5    Yao, P.L.6
  • 104
    • 0344962391 scopus 로고    scopus 로고
    • Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity
    • COI: 1:CAS:528:DC%2BD3sXptVWmsLs%3D, PID: 14637190
    • Leu TH, Su SL, Chuang YC, Maa MC. Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity. Biochem Pharmacol. 2003;66:2323–31.
    • (2003) Biochem Pharmacol , vol.66 , pp. 2323-2331
    • Leu, T.H.1    Su, S.L.2    Chuang, Y.C.3    Maa, M.C.4
  • 105
    • 84964037860 scopus 로고    scopus 로고
    • A curcumin analog, GO-Y078, effectively inhibits angiogenesis through actin disorganization
    • COI: 1:CAS:528:DC%2BC28Xlt1Kgsr4%3D
    • Sugiyama S, Yoshino Y, Kuriyama S, Inoue M, Komine K, Otsuka K, et al. A curcumin analog, GO-Y078, effectively inhibits angiogenesis through actin disorganization. Anti Cancer Agents Med Chem. 2016;16:633–47.
    • (2016) Anti Cancer Agents Med Chem , vol.16 , pp. 633-647
    • Sugiyama, S.1    Yoshino, Y.2    Kuriyama, S.3    Inoue, M.4    Komine, K.5    Otsuka, K.6
  • 106
    • 84937549900 scopus 로고    scopus 로고
    • Study on anti-angiogenesis effect of three curcumin pigments and expression of their relevant factors
    • PID: 26080567
    • Huang YF, Zhu XX, Ding ZS, Lv GY. Study on anti-angiogenesis effect of three curcumin pigments and expression of their relevant factors. Zhongguo Zhong Yao Za Zhi. 2015;40:324–9.
    • (2015) Zhongguo Zhong Yao Za Zhi , vol.40 , pp. 324-329
    • Huang, Y.F.1    Zhu, X.X.2    Ding, Z.S.3    Lv, G.Y.4
  • 107
    • 84904913128 scopus 로고    scopus 로고
    • Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells
    • COI: 1:CAS:528:DC%2BC2cXht1Kjur%2FO, PID: 24779927
    • Zhang F, Zhang Z, Chen L, Kong D, Zhang X, Lu C, et al. Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. J Cell Mol Med. 2014;18:1392–406.
    • (2014) J Cell Mol Med , vol.18 , pp. 1392-1406
    • Zhang, F.1    Zhang, Z.2    Chen, L.3    Kong, D.4    Zhang, X.5    Lu, C.6
  • 108
    • 4143140856 scopus 로고    scopus 로고
    • Trans-3,4,5′-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells
    • COI: 1:CAS:528:DC%2BD2cXmtlSiu7Y%3D, PID: 15297429
    • Cao Z, Fang J, Xia C, Shi X, Jiang BH. Trans-3,4,5′-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res. 2004;10:5253–63.
    • (2004) Clin Cancer Res , vol.10 , pp. 5253-5263
    • Cao, Z.1    Fang, J.2    Xia, C.3    Shi, X.4    Jiang, B.H.5
  • 109
    • 84902656268 scopus 로고    scopus 로고
    • Resveratrol inhibits VEGF gene expression and proliferation of hepatocarcinoma cells
    • COI: 1:CAS:528:DC%2BC2cXptlSmtro%3D, PID: 24901151
    • Zhang H, Yang R. Resveratrol inhibits VEGF gene expression and proliferation of hepatocarcinoma cells. Hepato-Gastroenterology. 2014;61:410–2.
    • (2014) Hepato-Gastroenterology , vol.61 , pp. 410-412
    • Zhang, H.1    Yang, R.2
  • 110
    • 84891927761 scopus 로고    scopus 로고
    • A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1alpha and VEGF expression, and migration in human prostate cancer cells
    • COI: 1:CAS:528:DC%2BC3sXhvFaks7vI, PID: 24100602
    • Kim DH, Hossain MA, Kim MY, Kim JA, Yoon JH, Suh HS, et al. A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1alpha and VEGF expression, and migration in human prostate cancer cells. Int J Oncol. 2013;43:1915–24.
    • (2013) Int J Oncol , vol.43 , pp. 1915-1924
    • Kim, D.H.1    Hossain, M.A.2    Kim, M.Y.3    Kim, J.A.4    Yoon, J.H.5    Suh, H.S.6
  • 111
    • 54949114722 scopus 로고    scopus 로고
    • Antitumor activities of synthetic and natural stilbenes through antiangiogenic action
    • COI: 1:CAS:528:DC%2BD1cXhsVGltr7J, PID: 19016770
    • Kimura Y, Sumiyoshi M, Baba K. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action. Cancer Sci. 2008;99:2083–96.
    • (2008) Cancer Sci , vol.99 , pp. 2083-2096
    • Kimura, Y.1    Sumiyoshi, M.2    Baba, K.3
  • 112
    • 77949658533 scopus 로고    scopus 로고
    • Transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol
    • COI: 1:CAS:528:DC%2BC3cXjtVClt7c%3D, PID: 20012470
    • Srivastava RK, Unterman TG, Shankar SFOXO. Transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol. Mol Cell Biochem. 2010;337:201–12.
    • (2010) Mol Cell Biochem , vol.337 , pp. 201-212
    • Srivastava, R.K.1    Unterman, T.G.2    Shankar, S.F.O.X.O.3
  • 113
    • 0141537877 scopus 로고    scopus 로고
    • Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-κB activation
    • COI: 1:CAS:528:DC%2BD3sXns12lurw%3D, PID: 14527676
    • Aldieri E, Atragene D, Bergandi L, Riganti C, Costamagna C, Bosia A, et al. Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-κB activation. FEBS Lett. 2003;552:141–4.
    • (2003) FEBS Lett , vol.552 , pp. 141-144
    • Aldieri, E.1    Atragene, D.2    Bergandi, L.3    Riganti, C.4    Costamagna, C.5    Bosia, A.6
  • 115
    • 0043095357 scopus 로고    scopus 로고
    • Baicalein and baicalin are potent inhibitors of angiogenesis: inhibition of endothelial cell proliferation, migration and differentiation
    • COI: 1:CAS:528:DC%2BD3sXmtl2js78%3D, PID: 12845652
    • Liu JJ, Huang TS, Cheng WF, Lu FJ. Baicalein and baicalin are potent inhibitors of angiogenesis: inhibition of endothelial cell proliferation, migration and differentiation. Int J Cancer. 2003;106:559–65.
    • (2003) Int J Cancer , vol.106 , pp. 559-565
    • Liu, J.J.1    Huang, T.S.2    Cheng, W.F.3    Lu, F.J.4
  • 116
    • 67649449180 scopus 로고    scopus 로고
    • Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
    • COI: 1:CAS:528:DC%2BD1MXlvFShs70%3D, PID: 19472429
    • Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. 2009;9:429–39.
    • (2009) Nat Rev Cancer , vol.9 , pp. 429-439
    • Yang, C.S.1    Wang, X.2    Lu, G.3    Picinich, S.C.4
  • 117
    • 0035937335 scopus 로고    scopus 로고
    • EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells
    • COI: 1:CAS:528:DC%2BD3MXivVGrt7Y%3D, PID: 11259102
    • Jung YD, Kim MS, Shin BA, Chay KO, Ahn BW, Liu W, et al. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer. 2001;84:844–50.
    • (2001) Br J Cancer , vol.84 , pp. 844-850
    • Jung, Y.D.1    Kim, M.S.2    Shin, B.A.3    Chay, K.O.4    Ahn, B.W.5    Liu, W.6
  • 118
    • 0036801990 scopus 로고    scopus 로고
    • Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability
    • COI: 1:CAS:528:DC%2BD38Xos1ekur8%3D
    • Lee MJ, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S, et al. Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomark Prev. 2002;11:1025–32.
    • (2002) Cancer Epidemiol Biomark Prev , vol.11 , pp. 1025-1032
    • Lee, M.J.1    Maliakal, P.2    Chen, L.3    Meng, X.4    Bondoc, F.Y.5    Prabhu, S.6
  • 119
    • 18444364494 scopus 로고    scopus 로고
    • Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells
    • COI: 1:CAS:528:DC%2BD38XmtF2qt7o%3D, PID: 12163680
    • Sartippour MR, Shao ZM, Heber D, Beatty P, Zhang L, Liu C, et al. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr. 2002;132:2307–11.
    • (2002) J Nutr , vol.132 , pp. 2307-2311
    • Sartippour, M.R.1    Shao, Z.M.2    Heber, D.3    Beatty, P.4    Zhang, L.5    Liu, C.6
  • 120
    • 34247165443 scopus 로고    scopus 로고
    • (−)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis
    • COI: 1:CAS:528:DC%2BD2sXltlWht7o%3D, PID: 17451194
    • Zhu BH, Zhan WH, Li ZR, Wang Z, He YL, Peng JS, et al. (−)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis. World J Gastroenterol. 2007;13:1162–9.
    • (2007) World J Gastroenterol , vol.13 , pp. 1162-1169
    • Zhu, B.H.1    Zhan, W.H.2    Li, Z.R.3    Wang, Z.4    He, Y.L.5    Peng, J.S.6
  • 121
    • 0033118504 scopus 로고    scopus 로고
    • Angiogenesis inhibited by drinking tea
    • COI: 1:CAS:528:DyaK1MXisFGmtLw%3D, PID: 10201368
    • Cao Y, Cao R. Angiogenesis inhibited by drinking tea. Nature. 1999;398:381.
    • (1999) Nature , vol.398 , pp. 381
    • Cao, Y.1    Cao, R.2
  • 122
    • 33847292778 scopus 로고    scopus 로고
    • From Tpr-Met to Met, tumorigenesis and tubes
    • COI: 1:CAS:528:DC%2BD2sXitVKhs7k%3D, PID: 17322912
    • Peschard P, Park M. From Tpr-Met to Met, tumorigenesis and tubes. Oncogene. 2007;26:1276–85.
    • (2007) Oncogene , vol.26 , pp. 1276-1285
    • Peschard, P.1    Park, M.2
  • 123
    • 68949110352 scopus 로고    scopus 로고
    • Phase I trial of daily oral polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia
    • COI: 1:CAS:528:DC%2BD1MXhtFaitrrM, PID: 19470922
    • Shanafelt TD, Call TG, Zent CS, LaPlant B, Bowen DA, Roos M, et al. Phase I trial of daily oral polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J Clin Oncol. 2009;27:3808–14.
    • (2009) J Clin Oncol , vol.27 , pp. 3808-3814
    • Shanafelt, T.D.1    Call, T.G.2    Zent, C.S.3    LaPlant, B.4    Bowen, D.A.5    Roos, M.6
  • 124
    • 84872058507 scopus 로고    scopus 로고
    • Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia
    • COI: 1:CAS:528:DC%2BC3sXjs1yquw%3D%3D, PID: 22760587
    • Shanafelt TD, Call TG, Zent CS, Leis JF, LaPlant B, Bowen DA, et al. Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Cancer. 2013;119:363–70.
    • (2013) Cancer , vol.119 , pp. 363-370
    • Shanafelt, T.D.1    Call, T.G.2    Zent, C.S.3    Leis, J.F.4    LaPlant, B.5    Bowen, D.A.6
  • 125
    • 84896078460 scopus 로고    scopus 로고
    • A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer
    • COI: 1:CAS:528:DC%2BC2cXhtF2ntr0%3D, PID: 24444526
    • Zhao H, Zhu W, Xie P, Li H, Zhang X, Sun X, et al. A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer. Radiother Oncol. 2014;110:132–6.
    • (2014) Radiother Oncol , vol.110 , pp. 132-136
    • Zhao, H.1    Zhu, W.2    Xie, P.3    Li, H.4    Zhang, X.5    Sun, X.6
  • 126
    • 84957928314 scopus 로고    scopus 로고
    • Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy
    • PID: 26607642
    • Zhao H, Zhu W, Jia L, Sun X, Chen G, Zhao X, et al. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy. Br J Radiol. 2016;89:20150665.
    • (2016) Br J Radiol , vol.89 , pp. 20150665
    • Zhao, H.1    Zhu, W.2    Jia, L.3    Sun, X.4    Chen, G.5    Zhao, X.6
  • 127
    • 13844293171 scopus 로고    scopus 로고
    • Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-catenin-mediated transactivation and cell-cell adhesion pathways
    • COI: 1:CAS:528:DC%2BD2cXltVWqs78%3D, PID: 15339049
    • Narayan S. Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-catenin-mediated transactivation and cell-cell adhesion pathways. J Mol Histol. 2004;35:301–7.
    • (2004) J Mol Histol , vol.35 , pp. 301-307
    • Narayan, S.1
  • 128
    • 84920564406 scopus 로고    scopus 로고
    • Curcumin and quercetin trigger apoptosis during benzo(a)pyrene-induced lung carcinogenesis
    • COI: 1:CAS:528:DC%2BC2cXhvVOltbjP, PID: 25359171
    • Nair P, Malhotra A, Dhawan DK. Curcumin and quercetin trigger apoptosis during benzo(a)pyrene-induced lung carcinogenesis. Mol Cell Biochem. 2015;400:51–6.
    • (2015) Mol Cell Biochem , vol.400 , pp. 51-56
    • Nair, P.1    Malhotra, A.2    Dhawan, D.K.3
  • 129
    • 0037236792 scopus 로고    scopus 로고
    • Anticancer potential of curcumin: preclinical and clinical studies
    • COI: 1:CAS:528:DC%2BD3sXislaqtLo%3D, PID: 12680238
    • Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23:363–98.
    • (2003) Anticancer Res , vol.23 , pp. 363-398
    • Aggarwal, B.B.1    Kumar, A.2    Bharti, A.C.3
  • 130
    • 0030325632 scopus 로고    scopus 로고
    • Strategy and planning for chemopreventive drug development: clinical development plans II
    • COI: 1:STN:280:DyaK2s3pvVOmsA%3D%3D, PID: 9154168
    • Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet RA, Boone CW, et al. Strategy and planning for chemopreventive drug development: clinical development plans II. J Cell Biochem Suppl. 1996;26:54–71.
    • (1996) J Cell Biochem Suppl , vol.26 , pp. 54-71
    • Kelloff, G.J.1    Crowell, J.A.2    Hawk, E.T.3    Steele, V.E.4    Lubet, R.A.5    Boone, C.W.6
  • 131
    • 84907270545 scopus 로고    scopus 로고
    • Regulation of biokinetics of (65)Zn by curcumin and zinc in experimentally induced colon carcinogenesis in rats
    • COI: 1:CAS:528:DC%2BC2cXhs1OktLfF, PID: 25226565
    • Jain K, Dhawan DK. Regulation of biokinetics of (65)Zn by curcumin and zinc in experimentally induced colon carcinogenesis in rats. Cancer Biother Radiopharm. 2014;29:310–6.
    • (2014) Cancer Biother Radiopharm , vol.29 , pp. 310-316
    • Jain, K.1    Dhawan, D.K.2
  • 132
    • 84934438047 scopus 로고    scopus 로고
    • Curcumin as an inhibitor of angiogenesis
    • PID: 17569211
    • Bhandarkar SS, Arbiser JL. Curcumin as an inhibitor of angiogenesis. Adv Exp Med Biol. 2007;595:185–95.
    • (2007) Adv Exp Med Biol , vol.595 , pp. 185-195
    • Bhandarkar, S.S.1    Arbiser, J.L.2
  • 133
    • 84940861862 scopus 로고    scopus 로고
    • BDMC-A, an analog of curcumin, inhibits markers of invasion, angiogenesis, and metastasis in breast cancer cells via NF-kappaB pathway--a comparative study with curcumin
    • COI: 1:CAS:528:DC%2BC2MXht12kur7I, PID: 26349982
    • Mohankumar K, Sridharan S, Pajaniradje S, Singh VK, Ronsard L, Banerjea AC, et al. BDMC-A, an analog of curcumin, inhibits markers of invasion, angiogenesis, and metastasis in breast cancer cells via NF-kappaB pathway--a comparative study with curcumin. Biomed Pharmacother. 2015;74:178–86.
    • (2015) Biomed Pharmacother , vol.74 , pp. 178-186
    • Mohankumar, K.1    Sridharan, S.2    Pajaniradje, S.3    Singh, V.K.4    Ronsard, L.5    Banerjea, A.C.6
  • 134
    • 84930084889 scopus 로고    scopus 로고
    • Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy
    • COI: 1:CAS:528:DC%2BC2MXos1emtr0%3D, PID: 25979230
    • James MI, Iwuji C, Irving G, Karmokar A, Higgins JA, Griffin-Teal N, et al. Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy. Cancer Lett. 2015;364:135–41.
    • (2015) Cancer Lett , vol.364 , pp. 135-141
    • James, M.I.1    Iwuji, C.2    Irving, G.3    Karmokar, A.4    Higgins, J.A.5    Griffin-Teal, N.6
  • 136
    • 0035174504 scopus 로고    scopus 로고
    • Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
    • COI: 1:CAS:528:DC%2BD3MXovVWgtrg%3D, PID: 11712783
    • Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21:2895–900.
    • (2001) Anticancer Res , vol.21 , pp. 2895-2900
    • Cheng, A.L.1    Hsu, C.H.2    Lin, J.K.3    Hsu, M.M.4    Ho, Y.F.5    Shen, T.S.6
  • 138
    • 70349466801 scopus 로고    scopus 로고
    • The potential role of curcumin in patients with monoclonal gammopathy of undefined significance—its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker
    • COI: 1:CAS:528:DC%2BD1MXhtFars7rL, PID: 19737963
    • Golombick T, Diamond TH, Badmaev V, Manoharan A, Ramakrishna R. The potential role of curcumin in patients with monoclonal gammopathy of undefined significance—its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker. Clin Cancer Res. 2009;15:5917–22.
    • (2009) Clin Cancer Res , vol.15 , pp. 5917-5922
    • Golombick, T.1    Diamond, T.H.2    Badmaev, V.3    Manoharan, A.4    Ramakrishna, R.5
  • 139
    • 84908503753 scopus 로고    scopus 로고
    • Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial
    • COI: 1:CAS:528:DC%2BC2cXhslaksL7N, PID: 24648302
    • Panahi Y, Saadat A, Beiraghdar F, Sahebkar A. Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial. Phytother Res. 2014;28:1461–7.
    • (2014) Phytother Res , vol.28 , pp. 1461-1467
    • Panahi, Y.1    Saadat, A.2    Beiraghdar, F.3    Sahebkar, A.4
  • 140
    • 84880532170 scopus 로고    scopus 로고
    • Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients
    • COI: 1:CAS:528:DC%2BC3sXhtFOqsb7L, PID: 23745991
    • Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP, et al. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res. 2013;180:34–43.
    • (2013) Radiat Res , vol.180 , pp. 34-43
    • Ryan, J.L.1    Heckler, C.E.2    Ling, M.3    Katz, A.4    Williams, J.P.5    Pentland, A.P.6
  • 141
    • 84926662580 scopus 로고    scopus 로고
    • Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial
    • PID: 25872567
    • Irving GR, Iwuji CO, Morgan B, Berry DP, Steward WP, Thomas A, et al. Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial. Trials. 2015;16:110.
    • (2015) Trials , vol.16 , pp. 110
    • Irving, G.R.1    Iwuji, C.O.2    Morgan, B.3    Berry, D.P.4    Steward, W.P.5    Thomas, A.6
  • 142
    • 0035919661 scopus 로고    scopus 로고
    • Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia
    • COI: 1:CAS:528:DC%2BD3MXlsFansL0%3D, PID: 11508648
    • Huang SS, Tsai MC, Chih CL, Hung LM, Tsai SK. Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci. 2001;69:1057–65.
    • (2001) Life Sci , vol.69 , pp. 1057-1065
    • Huang, S.S.1    Tsai, M.C.2    Chih, C.L.3    Hung, L.M.4    Tsai, S.K.5
  • 143
    • 84867898263 scopus 로고    scopus 로고
    • A preliminary study of presence of resveratrol in skins and pulps of European and Japanese plum cultivars
    • COI: 1:CAS:528:DC%2BC38XpvVekt7k%3D, PID: 22763954
    • Sebastia N, Montoro A, Manes J, Soriano JM. A preliminary study of presence of resveratrol in skins and pulps of European and Japanese plum cultivars. J Sci Food Agric. 2012;92:3091–4.
    • (2012) J Sci Food Agric , vol.92 , pp. 3091-3094
    • Sebastia, N.1    Montoro, A.2    Manes, J.3    Soriano, J.M.4
  • 144
    • 77955088481 scopus 로고    scopus 로고
    • Resveratrol as a therapeutic agent for neurodegenerative diseases
    • COI: 1:CAS:528:DC%2BC3cXmsFSru7c%3D, PID: 20306310
    • Sun AY, Wang Q, Simonyi A, Sun GY. Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol. 2010;41:375–83.
    • (2010) Mol Neurobiol , vol.41 , pp. 375-383
    • Sun, A.Y.1    Wang, Q.2    Simonyi, A.3    Sun, G.Y.4
  • 145
    • 77950598607 scopus 로고    scopus 로고
    • Diabetes mellitus, inflammation, obesity: proposed treatment pathways for current and future therapies
    • COI: 1:CAS:528:DC%2BC3cXmtlWntLc%3D, PID: 20233909
    • Sonnett TE, Levien TL, Gates BJ, Robinson JD, Campbell RK. Diabetes mellitus, inflammation, obesity: proposed treatment pathways for current and future therapies. Ann Pharmacother. 2010;44:701–11.
    • (2010) Ann Pharmacother , vol.44 , pp. 701-711
    • Sonnett, T.E.1    Levien, T.L.2    Gates, B.J.3    Robinson, J.D.4    Campbell, R.K.5
  • 146
    • 80054690858 scopus 로고    scopus 로고
    • Caloric restriction
    • COI: 1:CAS:528:DC%2BC3MXhtlejsLnO
    • Speakman JR, Mitchell SE. Caloric restriction. Mol Asp Med. 2011;32:159–221.
    • (2011) Mol Asp Med , vol.32 , pp. 159-221
    • Speakman, J.R.1    Mitchell, S.E.2
  • 147
    • 77957286124 scopus 로고    scopus 로고
    • Modulatory effects of curcumin and resveratrol on lung carcinogenesis in mice
    • COI: 1:CAS:528:DC%2BC3cXht1Kmt7vM, PID: 20041413
    • Malhotra A, Nair P, Dhawan DK. Modulatory effects of curcumin and resveratrol on lung carcinogenesis in mice. Phytother Res. 2010;24:1271–7.
    • (2010) Phytother Res , vol.24 , pp. 1271-1277
    • Malhotra, A.1    Nair, P.2    Dhawan, D.K.3
  • 148
    • 84871542281 scopus 로고    scopus 로고
    • Curcumin and resveratrol in combination modulates benzo(a)pyrene-induced genotoxicity during lung carcinogenesis
    • COI: 1:CAS:528:DC%2BC2cXhs1OlurjK, PID: 22531968
    • Malhotra A, Nair P, Dhawan DK. Curcumin and resveratrol in combination modulates benzo(a)pyrene-induced genotoxicity during lung carcinogenesis. Hum Exp Toxicol. 2012;31:1199–206.
    • (2012) Hum Exp Toxicol , vol.31 , pp. 1199-1206
    • Malhotra, A.1    Nair, P.2    Dhawan, D.K.3
  • 150
    • 0035430177 scopus 로고    scopus 로고
    • Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes
    • COI: 1:CAS:528:DC%2BD3MXmsFejsrY%3D, PID: 11481234
    • Brakenhielm E, Cao R, Cao Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J. 2001;15:1798–800.
    • (2001) FASEB J , vol.15 , pp. 1798-1800
    • Brakenhielm, E.1    Cao, R.2    Cao, Y.3
  • 151
    • 80052572943 scopus 로고    scopus 로고
    • Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases—safety, pharmacokinetics, and pharmacodynamics
    • COI: 1:CAS:528:DC%2BC3MXht12ktb3E
    • Howells LM, Berry DP, Elliott PJ, Jacobson EW, Hoffmann E, Hegarty B, et al. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases—safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila). 2011;4:1419–25.
    • (2011) Cancer Prev Res (Phila) , vol.4 , pp. 1419-1425
    • Howells, L.M.1    Berry, D.P.2    Elliott, P.J.3    Jacobson, E.W.4    Hoffmann, E.5    Hegarty, B.6
  • 152
    • 84892929980 scopus 로고    scopus 로고
    • Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/beta-catenin signal pathway
    • COI: 1:CAS:528:DC%2BC3sXhslyls7zK, PID: 24244343
    • Ji Q, Liu X, Fu X, Zhang L, Sui H, Zhou L, et al. Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/beta-catenin signal pathway. PLoS One. 2013;8:e78700.
    • (2013) PLoS One , vol.8
    • Ji, Q.1    Liu, X.2    Fu, X.3    Zhang, L.4    Sui, H.5    Zhou, L.6
  • 153
    • 84859739725 scopus 로고    scopus 로고
    • Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer
    • COI: 1:CAS:528:DC%2BC38XlsFemuro%3D, PID: 22332908
    • Zhu W, Qin W, Zhang K, Rottinghaus GE, Chen YC, Kliethermes B, et al. Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer. Nutr Cancer. 2012;64:393–400.
    • (2012) Nutr Cancer , vol.64 , pp. 393-400
    • Zhu, W.1    Qin, W.2    Zhang, K.3    Rottinghaus, G.E.4    Chen, Y.C.5    Kliethermes, B.6
  • 154
    • 1042294559 scopus 로고    scopus 로고
    • Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria
    • PID: 15109558
    • Mueller MS, Runyambo N, Wagner I, Borrmann S, Dietz K, Heide L. Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria. Trans R Soc Trop Med Hyg. 2004;98:318–21.
    • (2004) Trans R Soc Trop Med Hyg , vol.98 , pp. 318-321
    • Mueller, M.S.1    Runyambo, N.2    Wagner, I.3    Borrmann, S.4    Dietz, K.5    Heide, L.6
  • 155
    • 4444261942 scopus 로고    scopus 로고
    • Artemisinin induces apoptosis in human cancer cells
    • COI: 1:CAS:528:DC%2BD2cXot1Cgur8%3D, PID: 15330172
    • Singh NP, Lai HC. Artemisinin induces apoptosis in human cancer cells. Anticancer Res. 2004;24:2277–80.
    • (2004) Anticancer Res , vol.24 , pp. 2277-2280
    • Singh, N.P.1    Lai, H.C.2
  • 156
    • 33746531759 scopus 로고    scopus 로고
    • Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins
    • COI: 1:CAS:528:DC%2BD28Xnt1agu7Y%3D, PID: 16432535
    • Anfosso L, Efferth T, Albini A, Pfeffer U. Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins. Pharmacogenomics J. 2006;6:269–78.
    • (2006) Pharmacogenomics J , vol.6 , pp. 269-278
    • Anfosso, L.1    Efferth, T.2    Albini, A.3    Pfeffer, U.4
  • 157
    • 84958055473 scopus 로고    scopus 로고
    • Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study
    • PID: 26793976
    • Konig M, von Hagens C, Hoth S, Baumann I, Walter-Sack I, Edler L, et al. Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study. Cancer Chemother Pharmacol. 2016;77:413–27.
    • (2016) Cancer Chemother Pharmacol , vol.77 , pp. 413-427
    • Konig, M.1    von Hagens, C.2    Hoth, S.3    Baumann, I.4    Walter-Sack, I.5    Edler, L.6
  • 158
    • 39149087695 scopus 로고    scopus 로고
    • Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial
    • COI: 1:CAS:528:DC%2BD1cXjtlygsro%3D, PID: 18241646
    • Zhang ZY, Yu SQ, Miao LY, Huang XY, Zhang XP, Zhu YP, et al. Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial. Zhong Xi Yi Jie He Xue Bao. 2008;6:134–8.
    • (2008) Zhong Xi Yi Jie He Xue Bao , vol.6 , pp. 134-138
    • Zhang, Z.Y.1    Yu, S.Q.2    Miao, L.Y.3    Huang, X.Y.4    Zhang, X.P.5    Zhu, Y.P.6
  • 159
    • 84855171058 scopus 로고    scopus 로고
    • First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers
    • COI: 1:CAS:528:DC%2BC38XhsFClt7o%3D, PID: 22199309
    • Jansen FH, Adoubi IJCK, DE Cnodder T, Jansen N, Tschulakow A, et al. First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers. Anticancer Res. 2011;31:4417–22.
    • (2011) Anticancer Res , vol.31 , pp. 4417-4422
    • Jansen, F.H.1    Adoubi, I.J.C.K.2    Cnodder, T.3    Jansen, N.4    Tschulakow, A.5
  • 160
    • 81055156169 scopus 로고    scopus 로고
    • Boswellic acid inhibits inflammatory angiogenesis in a murine sponge model
    • COI: 1:CAS:528:DC%2BC3MXhsVOksrzO, PID: 21864545
    • Saraswati S, Pandey M, Mathur R, Agrawal SS. Boswellic acid inhibits inflammatory angiogenesis in a murine sponge model. Microvasc Res. 2011;82:263–8.
    • (2011) Microvasc Res , vol.82 , pp. 263-268
    • Saraswati, S.1    Pandey, M.2    Mathur, R.3    Agrawal, S.S.4
  • 161
    • 33644536397 scopus 로고    scopus 로고
    • Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression
    • COI: 1:CAS:528:DC%2BD28Xhs1eru70%3D, PID: 16493072
    • Takada Y, Ichikawa H, Badmaev V, Aggarwal BB. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunol. 2006;176:3127–40.
    • (2006) J Immunol , vol.176 , pp. 3127-3140
    • Takada, Y.1    Ichikawa, H.2    Badmaev, V.3    Aggarwal, B.B.4
  • 162
    • 84954176344 scopus 로고    scopus 로고
    • Boswellia serrata preserves intestinal epithelial barrier from oxidative and inflammatory damage
    • PID: 25955295
    • Catanzaro D, Rancan S, Orso G, Dall’Acqua S, Brun P, Giron MC, et al. Boswellia serrata preserves intestinal epithelial barrier from oxidative and inflammatory damage. PLoS One. 2015;10:e0125375.
    • (2015) PLoS One , vol.10
    • Catanzaro, D.1    Rancan, S.2    Orso, G.3    Dall’Acqua, S.4    Brun, P.5    Giron, M.C.6
  • 163
    • 67651005688 scopus 로고    scopus 로고
    • Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis
    • COI: 1:CAS:528:DC%2BD1MXosV2msbc%3D, PID: 19567671
    • Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, et al. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res. 2009;69:5893–900.
    • (2009) Cancer Res , vol.69 , pp. 5893-5900
    • Pang, X.1    Yi, Z.2    Zhang, X.3    Sung, B.4    Qu, W.5    Lian, X.6
  • 164
    • 58649104212 scopus 로고    scopus 로고
    • Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1
    • COI: 1:CAS:528:DC%2BD1MXltV2ltA%3D%3D, PID: 19147543
    • Kunnumakkara AB, Nair AS, Sung B, Pandey MK, Aggarwal BB. Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1. Mol Cancer Res. 2009;7:118–28.
    • (2009) Mol Cancer Res , vol.7 , pp. 118-128
    • Kunnumakkara, A.B.1    Nair, A.S.2    Sung, B.3    Pandey, M.K.4    Aggarwal, B.B.5
  • 165
    • 84928715673 scopus 로고    scopus 로고
    • Acetyl-11-keto-beta-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy
    • COI: 1:CAS:528:DC%2BC2MXnt1egt78%3D, PID: 25913458
    • Lulli M, Cammalleri M, Fornaciari I, Casini G, Dal Monte M. Acetyl-11-keto-beta-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy. Exp Eye Res. 2015;135:67–80.
    • (2015) Exp Eye Res , vol.135 , pp. 67-80
    • Lulli, M.1    Cammalleri, M.2    Fornaciari, I.3    Casini, G.4    Dal Monte, M.5
  • 166
    • 80051552444 scopus 로고    scopus 로고
    • Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial
    • PID: 21287538
    • Kirste S, Treier M, Wehrle SJ, Becker G, Abdel-Tawab M, Gerbeth K, et al. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial. Cancer. 2011;117:3788–95.
    • (2011) Cancer , vol.117 , pp. 3788-3795
    • Kirste, S.1    Treier, M.2    Wehrle, S.J.3    Becker, G.4    Abdel-Tawab, M.5    Gerbeth, K.6
  • 168
    • 84942243088 scopus 로고    scopus 로고
    • Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial
    • COI: 1:STN:280:DC%2BC2Mfjt1Onsw%3D%3D, PID: 25967706
    • Togni S, Maramaldi G, Bonetta A, Giacomelli L, Di Pierro F. Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial. Eur Rev Med Pharmacol Sci. 2015;19:1338–44.
    • (2015) Eur Rev Med Pharmacol Sci , vol.19 , pp. 1338-1344
    • Togni, S.1    Maramaldi, G.2    Bonetta, A.3    Giacomelli, L.4    Di Pierro, F.5
  • 169
    • 77949269054 scopus 로고    scopus 로고
    • Gingko biloba extract reduces VEGF and CXCL-8/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate
    • PID: 19597830
    • Trompezinski S, Bonneville M, Pernet I, Denis A, Schmitt D, Viac J. Gingko biloba extract reduces VEGF and CXCL-8/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate. Arch Dermatol Res. 2010;302:183–9.
    • (2010) Arch Dermatol Res , vol.302 , pp. 183-189
    • Trompezinski, S.1    Bonneville, M.2    Pernet, I.3    Denis, A.4    Schmitt, D.5    Viac, J.6
  • 170
    • 68149131849 scopus 로고    scopus 로고
    • Extract of Ginkgo biloba promotes the expression of VEGF following subarachnoid hemorrhage in rats
    • COI: 1:CAS:528:DC%2BD1MXmtlyiu74%3D, PID: 19466634
    • Sun BL, Hu DM, Yuan H, Ye WJ, Wang XC, Xia ZL, et al. Extract of Ginkgo biloba promotes the expression of VEGF following subarachnoid hemorrhage in rats. Int J Neurosci. 2009;119:995–1005.
    • (2009) Int J Neurosci , vol.119 , pp. 995-1005
    • Sun, B.L.1    Hu, D.M.2    Yuan, H.3    Ye, W.J.4    Wang, X.C.5    Xia, Z.L.6
  • 171
    • 72949107155 scopus 로고    scopus 로고
    • Ginkgo biloba Extract EGb 761 exerts anti-angiogenic effects via activation of tyrosine phosphatases
    • PID: 19175691
    • Koltermann A, Liebl J, Furst R, Ammer H, Vollmar AM, Zahler S. Ginkgo biloba Extract EGb 761 exerts anti-angiogenic effects via activation of tyrosine phosphatases. J Cell Mol Med. 2009;13:2122–30.
    • (2009) J Cell Mol Med , vol.13 , pp. 2122-2130
    • Koltermann, A.1    Liebl, J.2    Furst, R.3    Ammer, H.4    Vollmar, A.M.5    Zahler, S.6
  • 172
    • 84954403243 scopus 로고    scopus 로고
    • Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation
    • COI: 1:CAS:528:DC%2BC2cXitVCks7vM, PID: 25492239
    • Tilley C, Deep G, Agarwal C, Wempe MF, Biedermann D, Valentova K, et al. Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation. Mol Carcinog. 2016;55:3–14.
    • (2016) Mol Carcinog , vol.55 , pp. 3-14
    • Tilley, C.1    Deep, G.2    Agarwal, C.3    Wempe, M.F.4    Biedermann, D.5    Valentova, K.6
  • 173
    • 84907291514 scopus 로고    scopus 로고
    • Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells
    • COI: 1:CAS:528:DC%2BC2cXhvFGgsL%2FF, PID: 25175149
    • Kim S, Jeon M, Lee J, Han J, Oh SJ, Jung T, et al. Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells. Oncol Rep. 2014;32:2230–6.
    • (2014) Oncol Rep , vol.32 , pp. 2230-2236
    • Kim, S.1    Jeon, M.2    Lee, J.3    Han, J.4    Oh, S.J.5    Jung, T.6
  • 174
    • 84986616711 scopus 로고    scopus 로고
    • Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells
    • PID: 25317410
    • Kil WH, Kim SM, Lee JE, Park KS, Nam SJ. Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells. Ann Surg Treat Res. 2014;87:167–73.
    • (2014) Ann Surg Treat Res , vol.87 , pp. 167-173
    • Kil, W.H.1    Kim, S.M.2    Lee, J.E.3    Park, K.S.4    Nam, S.J.5
  • 175
    • 16644391709 scopus 로고    scopus 로고
    • Differential effects of Viscum album extract IscadorQu on cell cycle progression and apoptosis in cancer cells
    • COI: 1:CAS:528:DC%2BD2MXhsVOktg%3D%3D, PID: 15547686
    • Harmsma M, Gromme M, Ummelen M, Dignef W, Tusenius KJ, Ramaekers FC. Differential effects of Viscum album extract IscadorQu on cell cycle progression and apoptosis in cancer cells. Int J Oncol. 2004;25:1521–9.
    • (2004) Int J Oncol , vol.25 , pp. 1521-1529
    • Harmsma, M.1    Gromme, M.2    Ummelen, M.3    Dignef, W.4    Tusenius, K.J.5    Ramaekers, F.C.6
  • 176
    • 0035216950 scopus 로고    scopus 로고
    • Inhibition of tumor growth and metastasis by Korean mistletoe lectin is associated with apoptosis and antiangiogenesis
    • COI: 1:CAS:528:DC%2BD38Xkt1Wlsg%3D%3D, PID: 11776761
    • Park WB, Lyu SY, Kim JH, Choi SH, Chung HK, Ahn SH, et al. Inhibition of tumor growth and metastasis by Korean mistletoe lectin is associated with apoptosis and antiangiogenesis. Cancer Biother Radiopharm. 2001;16:439–47.
    • (2001) Cancer Biother Radiopharm , vol.16 , pp. 439-447
    • Park, W.B.1    Lyu, S.Y.2    Kim, J.H.3    Choi, S.H.4    Chung, H.K.5    Ahn, S.H.6
  • 177
    • 20444444399 scopus 로고    scopus 로고
    • In vivo and in vitro effect of baicalein on human prostate cancer cells
    • COI: 1:CAS:528:DC%2BD2MXmsFWhug%3D%3D, PID: 15586246
    • Miocinovic R, McCabe NP, Keck RW, Jankun J, Hampton JA, Selman SH. In vivo and in vitro effect of baicalein on human prostate cancer cells. Int J Oncol. 2005;26:241–6.
    • (2005) Int J Oncol , vol.26 , pp. 241-246
    • Miocinovic, R.1    McCabe, N.P.2    Keck, R.W.3    Jankun, J.4    Hampton, J.A.5    Selman, S.H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.